CMS selects 10 medicine for value negotiation – Healthcare Economist

[ad_1]





Right here is the CMS Factsheet and information protection from NY Instances.

CMS selects 10 medicine for value negotiation – Healthcare Economist

The businesses that make every of those medicine is listed beneath.

  1. Eliquis – Bristol Myers Squibb and Pfizer
  2. Jardiance- Boehringer Ingelheim and Eli Lilly
  3. Xarelto – Johnson & Johnson
  4. Januvia – Merck
  5. Farxiga – AstraZeneca
  6. Entresto – Novartis
  7. Enbrel – Amgen
  8. Imbruvica,- AbbVie and Johnson & Johnson
  9. Stelara, – Johnson & Johnson
  10. Fiasp and NovoLog – Novo Nordisk



[ad_2]

Leave a Comment